Baystate Wealth Management LLC Gilead Sciences, Inc. Transaction History

Baystate Wealth Management LLC

$1.36 Billion
Q4 2023

A detailed history of Baystate Wealth Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Baystate Wealth Management LLC holds 888 shares of GILD stock, worth $82,211. This represents 0.01% of its overall portfolio holdings.

Number of Shares

888

Previous 578 53.63%

Holding current value

$82,211

Previous $43,000 65.12%

% of portfolio

0.01%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $22,713 - $25,757	310 Added 53.63%	888 $71,000
Q3 2023 Oct 25, 2023	BUY	$73.94 - $80.67 $11,460 - $12,503	155 Added 36.64%	578 $43,000
Q2 2023 Sep 21, 2023	SELL	$76.01 - $86.7 $1.09 Million - $1.24 Million	-14,314 Reduced 97.13%	423 $32,000
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $1.09 Million - $1.25 Million	14,378 Added 4005.01%	14,737 $1.14 Million
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $927 - $1,056	-12 Reduced 3.23%	359 $29,000
Q4 2022 Jan 12, 2023	BUY	$62.32 - $89.47 $1,121 - $1,610	18 Added 5.1%	371 $32,000
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $238 - $272	4 Added 1.15%	353 $22,000
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $230 - $260	4 Added 1.16%	349 $22,000
Q1 2022 Apr 19, 2022	BUY	$57.92 - $72.58 $231 - $290	4 Added 1.17%	345 $21,000
Q4 2021 Jan 21, 2022	BUY	$64.88 - $73.64 $259 - $294	4 Added 1.19%	341 $25,000
Q3 2021 Nov 05, 2021	BUY	$67.69 - $73.03 $203 - $219	3 Added 0.9%	337 $24,000
Q2 2021 Jul 26, 2021	BUY	$63.47 - $69.35 $253 - $277	4 Added 1.21%	334 $23,000
Q1 2021 Apr 21, 2021	SELL	$60.0 - $68.46 $5,640 - $6,435	-94 Reduced 22.17%	330 $21,000
Q4 2020 Jan 15, 2021	SELL	$56.65 - $64.55 $6,004 - $6,842	-106 Reduced 20.0%	424 $25,000
Q3 2020 Oct 14, 2020	SELL	$62.1 - $78.08 $10,060 - $12,648	-162 Reduced 23.41%	530 $33,000
Q2 2020 Jul 28, 2020	BUY	$72.34 - $84.0 $12,514 - $14,532	173 Added 33.33%	692 $53,000
Q1 2020 Apr 22, 2020	SELL	$62.63 - $80.22 $7,202 - $9,225	-115 Reduced 18.14%	519 $39,000
Q4 2019 Jan 21, 2020	BUY	$61.62 - $67.78 $7,147 - $7,862	116 Added 22.39%	634 $41,000
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $6,501 - $7,176	-104 Reduced 16.72%	518 $33,000
Q2 2019 Jul 02, 2019	SELL	$61.87 - $69.38 $16,952 - $19,010	-274 Reduced 30.58%	622 $42,000
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $16,507 - $18,493	-264 Reduced 22.76%	896 $56,000
Q4 2018 Jan 24, 2019	BUY	$60.54 - $79.0 $17,496 - $22,831	289 Added 33.18%	1,160 $80,000
Q3 2018 Oct 16, 2018	SELL	$71.28 - $78.92 $1,924 - $2,130	-27 Reduced 3.01%	871 $65,000
Q2 2018 Jul 17, 2018	BUY	$64.88 - $75.68 $454 - $529	7 Added 0.79%	898 $68,000
Q1 2018 Apr 24, 2018	SELL	$72.84 - $88.8 $3,277 - $3,996	-45 Reduced 4.81%	891 $66,000
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $71 - $83	-1 Reduced 0.11%	936 $76,000
Q3 2017 Oct 10, 2017	BUY	$72.11 - $85.47 $67,567 - $80,085	937	937 $77,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.

Account

Baystate Wealth Management LLC Gilead Sciences, Inc. Transaction History